AU2001230587A1 - Drugs for ameliorating impaired glucose tolerance - Google Patents

Drugs for ameliorating impaired glucose tolerance

Info

Publication number
AU2001230587A1
AU2001230587A1 AU2001230587A AU3058701A AU2001230587A1 AU 2001230587 A1 AU2001230587 A1 AU 2001230587A1 AU 2001230587 A AU2001230587 A AU 2001230587A AU 3058701 A AU3058701 A AU 3058701A AU 2001230587 A1 AU2001230587 A1 AU 2001230587A1
Authority
AU
Australia
Prior art keywords
drugs
glucose tolerance
impaired glucose
ameliorating impaired
ameliorating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001230587A
Other languages
English (en)
Inventor
Michiko Kishino
Mutsuo Taiji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU2001230587A1 publication Critical patent/AU2001230587A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AU2001230587A 2000-02-18 2001-02-07 Drugs for ameliorating impaired glucose tolerance Abandoned AU2001230587A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000040585 2000-02-18
JP2000-40585 2000-02-18
PCT/JP2001/000837 WO2001060398A1 (fr) 2000-02-18 2001-02-07 Medicaments destines a ameliorer l'intolerance au glucose

Publications (1)

Publication Number Publication Date
AU2001230587A1 true AU2001230587A1 (en) 2001-08-27

Family

ID=18563945

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001230587A Abandoned AU2001230587A1 (en) 2000-02-18 2001-02-07 Drugs for ameliorating impaired glucose tolerance

Country Status (4)

Country Link
US (1) US20030022840A1 (fr)
EP (1) EP1270011A4 (fr)
AU (1) AU2001230587A1 (fr)
WO (1) WO2001060398A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1720564A1 (fr) * 2004-02-20 2006-11-15 Rinat Neuroscience Corp. Methodes de traitement de l'obesite ou de diabetes au moyen de nt-4/5
WO2007088479A1 (fr) * 2006-02-02 2007-08-09 Rinat Neuroscience Corp. Procédés de traitement de l'obésité par administration d'un antagoniste trkb
BRPI0707482A2 (pt) * 2006-02-02 2011-05-03 Rinat Neuroscience Corp métodos para tratar perda indesejada de peso ou distúbios de alimentação por administração de um agonista de trkb, bem como uso de nt-4/5 e de um agonista de trkb
RU2009123491A (ru) * 2006-12-20 2010-12-27 Ринат Ньюросайенс Корпорейшн (Us) АГОНИСТЫ TrkB ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ НАРУШЕНИЙ
WO2010086828A2 (fr) * 2009-02-02 2010-08-05 Rinat Neuroscience Corporation Anticorps monoclonaux agonistes anti-trkb

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
CA2262647C (fr) * 1996-08-08 2007-12-04 Amylin Pharmaceuticals, Inc. Methodes de regulation de la motilite gastro-intestinale
IT1288388B1 (it) * 1996-11-19 1998-09-22 Angeletti P Ist Richerche Bio Uso di sostanze che attivano il recettore del cntf ( fattore neurotrofico ciliare) per la preparazione di farmaci per la terapia
EP1010432A4 (fr) * 1997-01-23 2004-03-10 Sumitomo Pharma Remedes contre le diabete

Also Published As

Publication number Publication date
EP1270011A4 (fr) 2003-06-11
WO2001060398A1 (fr) 2001-08-23
WO2001060398A8 (fr) 2003-02-13
EP1270011A1 (fr) 2003-01-02
US20030022840A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
AU2002217979A1 (en) Medicine feeder
AU5259100A (en) Medicament
AU2754700A (en) Busy-wait-free synchronization
AU2002213377A1 (en) Synchronized computing
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU2002244154A1 (en) Divalproex sodium tablets
AU2001240856A1 (en) Capsules
AU5606000A (en) Event clock
AU2002253039A1 (en) Tramadol-based medicament
AU2001240838A1 (en) Capsules
AU2002214006A1 (en) Drugs for diabetes
AU2002356307A1 (en) Fault-tolerant clock synchronisation
AU2002221099A1 (en) Combination drugs
AU2001243515A1 (en) Combination drug therapy
AU6196600A (en) Medication reminder system
AU2692200A (en) Enteral sorbefacients
AU1645700A (en) Oenothein medicaments
AU2001232244A1 (en) Drug comprising combination
AU3533601A (en) Pacifier
AU2001230587A1 (en) Drugs for ameliorating impaired glucose tolerance
AU2002333276A1 (en) Drugs for vasculopaties
AU2001291691A1 (en) Drugs for incontinence
AU2001267135A1 (en) Medicaments
AU2001297710A1 (en) Integrated drug development techniques
AU2002320698A1 (en) Drugs for ameliorating postcibal hyperglycemia